Proteoglycan (aggrecan)-induced progressive polyarthritis is a novel, autoimmune animal model which shows many similarities to human rheumatoid arthritis and ankylosing spondylitis, as indicated by clinical assessments and histopathologic studies of diarthrodial joints and spine. The disease is induced by intraperitoneal immunization of BALB/c mice with a select group of proteoglycans isolated from human, dog and swine cartilages. Proteoglycans from other species tested to date do not induce arthritis. The development of the disease in genetically susceptible BALB/c mice is dependent upon the expression of both cell-mediated and humoral immunities to host mouse cartilage proteoglycans. The glycosaminoglycan side chains of the proteoglycans most likely are not included in the """"""""arthritogenic"""""""" epitopes, but their presence significantly inhibits the immune recognition of core protein epitopes. Recently, (1) the applicants isolated core protein fragments from canine articular cartilage and localized an arthritogenic segment at the N- terminal end of the interglobular domain. (2) generated aggrecan- specific T cell hybridomas, one of which is arthritogenic (5/4E-810), if injected with autoantibodies to mouse proteoglycan. (3) selected autoreactive monoclonal antibodies to mouse aggrecan which induce arthritis, if a pool of these antibodies are injected with T lymphocytes from arthritic animals. Thus, the investigators hypothesize that (1) there exist more than one autoimmune epitope in arthritogenic proteoglycans, which may be different for T and B lymphocytes and (2) both T- and B-cell mediated autoimmune responses are required for the development of the disease. They propose to investigate this hypothesis by determining the primary structure of arthritogenic epitopes which are most likely located in relatively short segments of the core protein of the aggrecans. This proposal is a continuation of the current project and will focus upon a few as yet unknown aspects of proteoglycan-induced arthritis: (1) What are the common amino acid sequences of arthritogenic (fetal human, canine and mouse) cartilage PGs which are absent (or different) in non- arthritogenic (e.g., bovine and rat chondrosarcoma) PGs? (2) Are these """"""""common"""""""" structures able to induce an autoimmune response and/or arthritis in BALB/c mice? (3) Is there any yet unidentified alternative splicing or polymorphism at the level of the genes coding for arthritogenic PGs? (4) Is there any link between autoimmune responses in arthritis and alternative splicing events of cartilage PGs? Answers to these questions are important for the understanding of autoimmunity to cartilage matrix components responsible for human rheumatoid joint diseases, may facilitate the development of early diagnosis of such diseases and may suggest prospective gene therapy regimens for use in susceptible individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040310-10
Application #
2882267
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Serrate-Sztein, Susana
Project Start
1990-03-01
Project End
2000-02-29
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kugyelka, Reka; Kohl, Zoltan; Olasz, Katalin et al. (2016) Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis. Mediators Inflamm 2016:6145810
Haynes, Katelin R; Pettit, Allison R; Duan, Ran et al. (2012) Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther 14:R253
Kis-Toth, Katalin; Radacs, Marianna; Olasz, Katalin et al. (2012) Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice. Int Immunol 24:507-17
Olasz, K; Boldizsar, F; Kis-Toth, K et al. (2012) T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice. Clin Exp Immunol 167:346-55
Besenyei, Timea; Kadar, Andras; Tryniszewska, Beata et al. (2012) Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models. Clin Dev Immunol 2012:284751
Kezic, Jelena M; Davey, Michael P; Glant, Tibor T et al. (2012) Interferon-? regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis. Arthritis Rheum 64:762-71
Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida et al. (2011) TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin. J Biol Chem 286:23559-69
Ghassemi-Nejad, S; Kobezda, T; Rauch, T A et al. (2011) Osteoarthritis-like damage of cartilage in the temporomandibular joints in mice with autoimmune inflammatory arthritis. Osteoarthritis Cartilage 19:458-65
Glant, Tibor T; Radacs, Marianna; Nagyeri, Gyorgy et al. (2011) Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum 63:1312-21
Angyal, Adrienn; Egelston, Colt; Kobezda, Tamas et al. (2010) Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Arthritis Res Ther 12:R44

Showing the most recent 10 out of 71 publications